DK1165576T3 - Fremgangsmåde til fremstilling af amin-platin-komplekser - Google Patents

Fremgangsmåde til fremstilling af amin-platin-komplekser

Info

Publication number
DK1165576T3
DK1165576T3 DK00918620T DK00918620T DK1165576T3 DK 1165576 T3 DK1165576 T3 DK 1165576T3 DK 00918620 T DK00918620 T DK 00918620T DK 00918620 T DK00918620 T DK 00918620T DK 1165576 T3 DK1165576 T3 DK 1165576T3
Authority
DK
Denmark
Prior art keywords
amine
preparation
platinum complexes
complexes
platinum
Prior art date
Application number
DK00918620T
Other languages
English (en)
Inventor
Ernest S Y Wong
Christen M Giandomenico
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of DK1165576T3 publication Critical patent/DK1165576T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00918620T 1999-04-13 2000-04-11 Fremgangsmåde til fremstilling af amin-platin-komplekser DK1165576T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12893999P 1999-04-13 1999-04-13

Publications (1)

Publication Number Publication Date
DK1165576T3 true DK1165576T3 (da) 2006-03-27

Family

ID=22437722

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00918620T DK1165576T3 (da) 1999-04-13 2000-04-11 Fremgangsmåde til fremstilling af amin-platin-komplekser

Country Status (32)

Country Link
US (1) US6518428B1 (da)
EP (1) EP1165576B1 (da)
JP (1) JP4756669B2 (da)
KR (1) KR100711955B1 (da)
CN (3) CN100460412C (da)
AR (1) AR043084A1 (da)
AT (1) ATE309257T1 (da)
AU (1) AU770006B2 (da)
BG (1) BG65429B1 (da)
BR (1) BR0009780B1 (da)
CA (1) CA2368849C (da)
CY (1) CY1104965T1 (da)
CZ (1) CZ303156B6 (da)
DE (1) DE60023859T2 (da)
DK (1) DK1165576T3 (da)
EE (1) EE04747B1 (da)
ES (1) ES2253214T3 (da)
HK (1) HK1039336B (da)
HU (1) HUP0200748A3 (da)
IL (1) IL145671A0 (da)
IS (1) IS2709B (da)
MX (1) MXPA01010430A (da)
MY (1) MY122706A (da)
NO (1) NO330429B1 (da)
NZ (1) NZ514736A (da)
PL (1) PL202731B1 (da)
RU (1) RU2245340C2 (da)
SK (1) SK286374B6 (da)
TW (1) TWI289565B (da)
UA (1) UA71614C2 (da)
WO (1) WO2000061590A1 (da)
ZA (1) ZA200107965B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
DK1165576T3 (da) 1999-04-13 2006-03-27 Anormed Inc Fremgangsmåde til fremstilling af amin-platin-komplekser
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6806289B1 (en) * 2000-07-14 2004-10-19 Stephen J. Lippard Coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same
US6894049B1 (en) * 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
WO2005077385A2 (en) 2004-02-18 2005-08-25 Gpc Biotech Ag Methods for treating resistant or refractory tumors
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
ES2257178B1 (es) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
RU2298556C1 (ru) * 2005-11-17 2007-05-10 Общество с ограниченной ответственностью "ЦитоСтарт" Триметилоламинометановая соль цис-бис [4-нитраминопиридин-n] тетрахлороплатины (iv) и способ ее получения
RU2309158C1 (ru) * 2006-03-27 2007-10-27 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения цис-дихлороамминизопропиламинплатины (ii)
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
TW200920347A (en) * 2007-07-16 2009-05-16 Poniard Pharmaceuticals Inc Oral formulations for picoplatin
AU2009210654A1 (en) * 2008-02-08 2009-08-13 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
TW201103867A (en) * 2009-06-12 2011-02-01 Poniard Pharmaceuticals Inc Improved synthesis of picoplatin
RU2451010C1 (ru) * 2011-01-11 2012-05-20 Закрытое Акционерное Общество "Ива Фарм" Палладиево-медные катализаторы гомогенного селективного окисления тиольных групп, комбинация и композиция на их основе и способ терапевтического воздействия
CN103554188B (zh) * 2013-11-19 2016-03-02 辽宁大学 6-(氮杂环取代)蒽醌二氯化铂配合物及其制备方法和应用
CN103860539B (zh) * 2014-04-14 2016-02-10 于迎涛 一种具有混合轴向配体的Pt（IV）类抗癌药物及制备方法
CN104231000A (zh) * 2014-08-20 2014-12-24 山东铂源药业有限公司 一种抗肿瘤药物甲啶铂的合成方法
US10987353B2 (en) 2016-05-04 2021-04-27 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
KR102137669B1 (ko) * 2019-08-05 2020-07-27 한국과학기술연구원 메탄올 또는 그 전구체 합성용 촉매, 이의 제조방법 및 이를 이용한 메탄올 또는 그 전구체의 제조방법
FI4178566T3 (fi) 2020-07-08 2026-05-21 Pharma& Schweiz Gmbh Satraplatiini käytettäväksi primaarisen keskushermostolymfooman (pcnsl) hoitoon
CN113402565B (zh) * 2021-06-16 2023-07-28 中国人民解放军空军军医大学 一类含有泊沙康唑的四价铂配合物、制备方法及其应用
EP4460582A1 (en) 2022-01-07 2024-11-13 pharma& Schweiz GmbH Treating haematological malignancies by means of satraplatin

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2060615B (en) * 1979-08-23 1983-06-22 Johnson Matthey Co Ltd Platinum-amine complexes
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
DE3582961D1 (de) * 1984-06-27 1991-07-04 Johnson Matthey Plc Platinkoordinationsverbindungen.
US5244919A (en) 1988-02-02 1993-09-14 Johnson Matthey, Inc. Pt(IV) complexes as anti-tumor agents
SU1790190A1 (ru) * 1990-08-08 1996-04-27 Ленинградский химико-фармацевтический институт Цис-хлордиаммин-1,3-диметилксантинплатины (ii) хлорид дигидрат, проявляющий противоопухолевую активность
GB9105037D0 (en) 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
RU2050361C1 (ru) * 1991-12-23 1995-12-20 Юрий Михайлович Островский Пентахлороплатинат (iv)-4- метил-3-[(2- метил-4- окси-5-пиримидинил) метил-]-5-(2 -оксиэтил)тиазолия, проявляющий противоопухолевую активность
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US5547982A (en) 1995-02-27 1996-08-20 Johnson Matthey, Inc. Anti-tumor platinum complexes
RU2089555C1 (ru) * 1995-05-04 1997-09-10 Новосибирский институт биоорганической химии СО РАН Бисимидазол-(1,10)-фенантролинплатина (iii) дихлорид, проявляющий цитостатическую противоопухолевую активность
CA2367282A1 (en) 1999-03-19 2000-09-28 Simon Fricker Pharmaceutical compositions comprising metal complexes
DK1165576T3 (da) 1999-04-13 2006-03-27 Anormed Inc Fremgangsmåde til fremstilling af amin-platin-komplekser

Also Published As

Publication number Publication date
HK1100562A1 (en) 2007-09-21
ATE309257T1 (de) 2005-11-15
CZ303156B6 (cs) 2012-05-09
CA2368849C (en) 2011-01-25
ZA200107965B (en) 2003-01-02
NO20014957L (no) 2001-12-03
CA2368849A1 (en) 2000-10-19
MXPA01010430A (es) 2002-03-27
NO330429B1 (no) 2011-04-11
WO2000061590A1 (en) 2000-10-19
HUP0200748A3 (en) 2010-01-28
NO20014957D0 (no) 2001-10-12
TWI289565B (en) 2007-11-11
EP1165576A1 (en) 2002-01-02
EP1165576B1 (en) 2005-11-09
US6518428B1 (en) 2003-02-11
CN100460412C (zh) 2009-02-11
BG65429B1 (bg) 2008-07-31
BR0009780B1 (pt) 2013-09-24
PL202731B1 (pl) 2009-07-31
PL351612A1 (en) 2003-05-05
IL145671A0 (en) 2002-06-30
CN1250559C (zh) 2006-04-12
EE200100536A (et) 2003-02-17
CN1916009B (zh) 2010-12-15
IS2711B3 (is) 2011-01-15
CN1847253A (zh) 2006-10-18
AR043084A1 (es) 2005-07-20
EE04747B1 (et) 2006-12-15
CN1916009A (zh) 2007-02-21
AU3951000A (en) 2000-11-14
BG106090A (en) 2002-06-28
KR100711955B1 (ko) 2007-05-02
CZ20013648A3 (cs) 2002-02-13
NZ514736A (en) 2004-01-30
BR0009780A (pt) 2002-01-02
JP4756669B2 (ja) 2011-08-24
ES2253214T3 (es) 2006-06-01
HK1039336A1 (en) 2002-04-19
HK1039336B (en) 2006-01-27
HUP0200748A2 (hu) 2002-07-29
UA71614C2 (en) 2004-12-15
MY122706A (en) 2006-04-29
IS6092A (is) 2001-09-28
IS2709B (is) 2011-01-15
SK14682001A3 (sk) 2002-01-07
SK286374B6 (sk) 2008-08-05
DE60023859D1 (de) 2005-12-15
CY1104965T1 (el) 2010-03-03
CN1350540A (zh) 2002-05-22
AU770006B2 (en) 2004-02-12
JP2002541263A (ja) 2002-12-03
DE60023859T2 (de) 2006-08-03
RU2245340C2 (ru) 2005-01-27
KR20020018189A (ko) 2002-03-07

Similar Documents

Publication Publication Date Title
EE04747B1 (et) Amiini-plaatina komplekside valmistamismeetod
DK1173431T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
IS5982A (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK1008577T4 (da) Fremgangsmåde til fremstilling af methanol
IS5952A (is) Aðferð til framleiðslu á 5-sýanóþalíði
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0985733T3 (da) Fremgangsmåde til fremstilling af cyclodextrin
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
DK0973769T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK1298124T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
DK0970073T3 (da) Fremgangsmåde til fremstilling af eprosartan
DK1240173T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin
DK1165483T3 (da) Fremgangsmåde til fremstilling af carbonylfluorid
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK1005476T3 (da) Fremgangsmåde til fremstilling af rutheniumkomplekser
DK1226125T3 (da) Fremgangsmåde til fremstilling af mavesårsmidler
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
DK0949246T3 (da) Fremgangsmåde til fremstilling af phenoxyphenylsulfonylhalogenider